Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.
Times cited: 3
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.
Times cited: 15
Long-term therapeutic efficacy and toxicity of recombinant interferon- alpha 2a in polycythaemia vera.
European Journal of Haematology.
Times cited: 16